Predictive methods for efficacy of house dust mite subcutaneous immunotherapy in allergic rhinitis patients: a prospective study in a Chinese population
ConclusionEfficacy of AIT at months 4, 6, 12, and 18 is strongly associated with efficacy at month 24. Efficacy as early as month 4 can predict efficacy at the second year, and this may help to determine the need for long ‐term treatment. Our findings may be useful for identifying novel treatment strategies for AIT.
Source: International Forum of Allergy and Rhinology - Category: Allergy & Immunology Authors: Zhuofu Liu,
Hanyu Lu,
Xian Feng,
Li Hu,
Jingjing Wang,
Hongmeng Yu Tags: ORIGINAL ARTICLE Source Type: research
More News: Allergy | Allergy & Immunology | Asthma | China Health | Hay Fever | Immunotherapy | Smokers | Study